 |
AC |  |
| ISIN | FR0000120404 |
| Security | AC |
| Exchange | ICE Europe |
| Type | Future |
Futures
| Exp. date | Last | Open Interest | |
|---|---|---|---|
| 8/20 | |||
| 9/20 | |||
| 10/20 | |||
| 11/20 | |||
| 12/20 | |||
| 1/21 | |||
| 2/21 | |||
| 3/21 | |||
| 4/21 | |||
| 5/21 | |||
| 6/21 | |||
| 7/21 | |||
| 8/21 | |||
| 9/21 | |||
| 10/21 | |||
| 11/21 | |||
| 12/21 | |||
| 1/22 | |||
| 2/22 | |||
| 3/22 | |||
| 4/22 | |||
| 5/22 | |||
| 6/22 | |||
| 7/22 | |||
| 8/22 | |||
| 9/22 | |||
| 10/22 | |||
| 11/22 | |||
| 12/22 | |||
| 1/23 | |||
| 2/23 | |||
| 3/23 | |||
| 4/23 | |||
| 5/23 | |||
| 6/23 | |||
| 7/23 | |||
| 8/23 | |||
| 9/23 | |||
| 10/23 | |||
| 11/23 | |||
| 12/23 | |||
| 1/24 | |||
| 2/24 | |||
| 3/24 | |||
| 4/24 | |||
| 5/24 | |||
| 6/24 | |||
| 7/24 | |||
| 8/24 | |||
| 9/24 | |||
| 10/24 | |||
| 11/24 | |||
| 12/24 | |||
| 1/25 | |||
| 2/25 | |||
| 3/25 | |||
| 4/25 | |||
| 5/25 |
News
- AC Immune Reports Q2 2020 Financial Results and Provides Business Update
13:00 - GlobeNewswire - AC Immune Initiates IND-Enabling Studies for First-in-Class Antibody Targeting TDP-43 to Treat Neurodegeneration
08/03/2020 / 13:00 - GlobeNewswire - AC Immune Wins Prestigious Award to Develop a “Game-Changing” Parkinson’s Diagnostic Tool
07/30/2020 / 13:55 - GlobeNewswire - AC Immune Demonstrates Enhanced Performance of First-in-class Parkinson’s Diagnostic Agent
07/28/2020 / 13:00 - GlobeNewswire - Arca Continental Reports Revenue Growth of 2.3% With EBITDA Up 1.8% in 2Q20
07/24/2020 / 14:15 - GlobeNewswire
Real-time